ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
3171Followers
0Topic
0Badge
ARKG Investment Tracker position change: Increased position in Kymera Therapeutics, Inc. by 42,725 shares, the number of shares held increased 96.14% compared to the previous period and now represents 0.47% of the total position.
ARKG Investment Tracker position change: Increased position in Freenome, Inc. by 52,775 shares, the number of shares held increased 6.02% compared to the previous period and now represents 0.72% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 19,446 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 8.58% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 248,402 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 2.85% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 26,194 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 3.31% of the total position.
ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 26,502 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 1.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Personalis by 290,009 shares, the number of shares held decreased 5.37% compared to the previous period and now represents 4.02% of the total position.
ARKG Investment Tracker position change: Decreased position in Eli Lilly by 1,092 shares, the number of shares held decreased 1.64% compared to the previous period and now represents 3.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 184,408 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 1.23% of the total position.
ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 16,604 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 1.25% of the total position.
ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 77,434 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 2.58% of the total position.
ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 125,299 shares, the number of shares held increased 6.48% compared to the previous period and now represents 2.24% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 30,786 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 2.33% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 14,700 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 1.85% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 37,870 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 2.9% of the total position.
ARKG Investment Tracker position change: Decreased position in Absci Corporation. by 178,472 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 4.63% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 9,814 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 4.72% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 4,158 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 4.72% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 6,230 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 4.79% of the total position.
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 35,994 shares, the number of shares held decreased 1.66% compared to the previous period and now represents 5.27% of the total position.
Go to Tiger App to see more news